ZNF638 and central nervous system cancer: To gain insight into the role of ZNF638 in shaping the epigenetic and immunological characteristics of GBM, we performed immune deconvolution using RNA sequencing from The Cancer Genome Atlas (TCGA) and validated results in an independent institutional cohort of high-grade gliomas (Figure 1B).